Zylö Receives $1,700,000 NIH Phase II Grant to Advance Erectile Dysfunction Program into Human Trials
20. Juli 2021 09:00 ET
|
Zylö Therapeutics
Funds to be used for scale-up, implementation of cGMP quality system, and pre-IND FDA meeting GREENVILLE, SC, July 20, 2021 (GLOBE NEWSWIRE) -- Zylö Therapeutics Inc., developer of the...
Zylö and Amifar Laboratorios Forge Broad-Ranging Partnership
19. Mai 2021 09:00 ET
|
Zylö Therapeutics
The Z-pod™ delivery system will further enhance the ‘Science of Beauty’ GREENVILLE, SC, May 19, 2021 (GLOBE NEWSWIRE) -- Zylö Therapeutics Inc., developer of the transformational Z-pod™ topical...
Charles E. Hinkle Joins Zylö as Chief Financial Officer
29. April 2021 09:30 ET
|
Zylö Therapeutics
GREENVILLE, SC, April 29, 2021 (GLOBE NEWSWIRE) -- Zylö Therapeutics Inc., developer of the transformational Z-pod™ topical delivery platform, announced that Charles E. Hinkle joined its executive...
Jay Blankenship M.D. Joins Zylö as Vice President of Business Development
01. September 2020 07:30 ET
|
Zylö Therapeutics
Michael Rabin shifts to Vice President of Strategy GREENVILLE, SC, Sept. 01, 2020 (GLOBE NEWSWIRE) -- Zylö Therapeutics Inc., developer of the transformational Z-pod™ topical delivery platform,...
Zylö and Grapefruit Forge Partnership That Promises to Disrupt the Topical Cannabis Market
28. Juli 2020 10:00 ET
|
Zylö Therapeutics
The Z-pod™ delivery system will help make Hourglass™ by Grapefruit a game-changer GREENVILLE, SC, July 28, 2020 (GLOBE NEWSWIRE) -- Zylö Therapeutics Inc., developer of the transformational...
Zylö Receives $225,000 NIH Grant to Further Develop Nitric-Oxide-Releasing Z-pods™ to Treat Erectile Dysfunction
12. November 2019 09:00 ET
|
Zylö Therapeutics
GREENVILLE, SC, Nov. 12, 2019 (GLOBE NEWSWIRE) -- Zylö Therapeutics Inc., developer of the transformational Z-pod™ topical delivery platform, has been awarded a $225,000 Small Business Technology...
Dr. Adam Friedman to Present Keynote at Dermatology Fall Update
07. November 2019 09:00 ET
|
Zylö Therapeutics
GREENVILLE, SC, Nov. 07, 2019 (GLOBE NEWSWIRE) -- Zylö Therapeutics Inc., developer of the transformational Z-pod™ topical delivery platform, announced that its scientific advisor, Adam Friedman MD,...
Zylö Therapeutics Closes $4 Million Series A Financing
26. September 2019 08:00 ET
|
Zylö Therapeutics
GREENVILLE, SC, Sept. 26, 2019 (GLOBE NEWSWIRE) -- Zylö Therapeutics Inc., dedicated to developing a transformational topical delivery platform, announced that on September 21, 2019, it effected a...
Seasoned Health Care Executive Michael Burns PhD Joins the Zylö Team as Vice President
18. September 2019 10:00 ET
|
Zylö Therapeutics
Greenville, SC, Sept. 18, 2019 (GLOBE NEWSWIRE) -- Zylö Therapeutics, dedicated to developing a transformational topical delivery platform, has welcomed Michael Burns PhD to its executive team as...
Zylö and Hoth Therapeutics Forge Partnership to Develop Endocannabinoid-Based Drug to Treat Lupus
22. August 2019 09:00 ET
|
Zylö Therapeutics
Zylö’s xerogel-derived delivery platform to be used to topically deliver the drug candidate Greenville, SC, Aug. 22, 2019 (GLOBE NEWSWIRE) -- Zylö Therapeutics, dedicated to bringing innovative...